Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...

Health charity Scleroderma & Raynaud's UK (SRUK) is urging the public to take a 60-second online test to find out if they may ...

OBJECTIVES: To evaluate the effect of minocycline as treatment for cutaneous calcinosis in limited cutaneous systemic sclerosis (lcSSc). METHODS: Patients with lcSSc who had cutaneous calcinosis ...

limited systemic sclerosis accounted for 66% of total cases, followed by diffuse systemic sclerosis in the US in 2023. . In age-specific cases, the 40–69 age group represented the highest ...

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of menopausal hormone therapy, according to data published in Rheumatology.